Editorial on "Can CT-PET and endoscopic assessment post-neoadjuvant chemoradiotherapy predict residual disease in esophageal cancer"
Journal
Journal of thoracic disease
Journal Volume
9
Journal Issue
10
Date Issued
2017-10
Author(s)
Lu, Wei
Abstract
Neoadjuvant chemoradiation (nCRT) followed by surgery is the most common treatment modality for resectable esophageal cancer nowadays (1). Esophagectomy and gastrointestinal continuity reconstruction are extensive and challenging procedures (2).
SDGs
Other Subjects
fluorodeoxyglucose f 18; cancer prognosis; cancer staging; chemoradiotherapy; Editorial; endoscopy; esophageal adenocarcinoma; esophageal squamous cell carcinoma; esophagus cancer; esophagus resection; human; micrometastasis; minimal residual disease; neoadjuvant therapy; omics; positron emission tomography-computed tomography; predictive value; radiomics; random forest; support vector machine; treatment response
Type
editorial